Fujian Aonong Biological Technology Group Incorporation Limited
SSE:603363.SS
3.77 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 1,383.913 | 207.661 | 719.076 | 542.982 | 570.94 | 254.99 | 170.861 | 228.942 | 174.267 | 192.848 | 88.594 | 129.679 |
| Short Term Investments
| 1.813 | 4.603 | 2.612 | 1.001 | 1.389 | -407.032 | -192.255 | -119.721 | -71.096 | -45.828 | -41.327 | -10.928 |
| Cash and Short Term Investments
| 1,385.726 | 212.264 | 721.688 | 543.983 | 572.329 | 254.99 | 170.861 | 228.942 | 174.267 | 192.848 | 88.594 | 129.679 |
| Net Receivables
| 1,132.21 | 897.819 | 515.164 | 816.073 | 449.057 | 435.469 | 491.331 | 345.194 | 267.91 | 272.549 | 166.35 | 0 |
| Inventory
| 816.936 | 1,328.135 | 3,288.7 | 2,588.853 | 1,730.811 | 599.27 | 433.159 | 392.057 | 285.27 | 242.671 | 242.418 | 233.442 |
| Other Current Assets
| 364.34 | 350.903 | 11.435 | 314.313 | 684.316 | 224.526 | 130.662 | 210.676 | 74.264 | 43.247 | 76.141 | 139.118 |
| Total Current Assets
| 3,699.212 | 2,789.121 | 5,115.341 | 4,263.224 | 3,524.31 | 1,514.255 | 1,226.012 | 1,176.869 | 801.711 | 751.314 | 554.689 | 502.24 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 4,210.676 | 8,730.578 | 9,968.263 | 9,507.767 | 5,438.885 | 2,386.877 | 1,506.319 | 951.438 | 601.982 | 391.563 | 199.231 | 123.249 |
| Goodwill
| 345.386 | 386.311 | 439.171 | 488.511 | 455.14 | 136.003 | 20.809 | 15.155 | 10.394 | 5.624 | 4.425 | 4.425 |
| Intangible Assets
| 328.814 | 424.38 | 651.198 | 462.697 | 374.463 | 207.063 | 176.948 | 143.228 | 99.641 | 72.487 | 43.409 | 17.293 |
| Goodwill and Intangible Assets
| 674.2 | 810.691 | 1,090.37 | 951.208 | 829.602 | 343.066 | 197.756 | 158.383 | 110.035 | 78.11 | 47.835 | 21.718 |
| Long Term Investments
| 165.948 | 331.593 | 303.799 | 174.353 | 200.525 | 484.214 | 276.118 | 143.755 | 88.531 | 51.87 | 46.578 | 17.195 |
| Tax Assets
| 142.074 | 166.892 | 250.347 | 150.766 | 155.235 | 107.457 | 66.524 | 59.844 | 57.009 | 49.672 | 39.261 | 25.564 |
| Other Non-Current Assets
| 613.987 | 796.338 | 1,932.45 | 2,053.209 | 1,870.137 | 85.798 | 32.3 | 47.794 | 52.438 | 25.702 | 39.269 | 20.48 |
| Total Non-Current Assets
| 5,806.885 | 10,836.092 | 13,545.228 | 12,837.303 | 8,494.385 | 3,407.413 | 2,079.017 | 1,361.215 | 909.995 | 596.918 | 372.173 | 208.207 |
| Total Assets
| 9,506.097 | 13,625.213 | 18,660.569 | 17,100.527 | 12,018.695 | 4,921.668 | 3,305.029 | 2,538.084 | 1,711.706 | 1,348.232 | 926.862 | 710.447 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 1,674.511 | 3,436.773 | 4,117.683 | 3,912.454 | 2,127.589 | 1,346.465 | 725.855 | 539.646 | 494.295 | 475.938 | 354.987 | 373.46 |
| Short Term Debt
| 765.327 | 5,044.465 | 3,974.546 | 3,653.889 | 2,679.687 | 1,211.815 | 926.774 | 495.353 | 236.925 | 207.85 | 184.117 | 57.5 |
| Tax Payables
| 30.872 | 15.025 | 50.269 | 35.347 | 29.486 | 10.363 | 9.404 | 16.616 | 10.044 | 13.432 | 6.665 | 18.49 |
| Deferred Revenue
| 0 | 0 | 252.9 | 1,459.752 | 1,062.561 | 425.375 | 9.404 | 120.025 | 72.966 | 74.07 | 81.043 | 120.87 |
| Other Current Liabilities
| 2,143.391 | 2,863.123 | 3,502.652 | 1,055.373 | 348.858 | 813.573 | 310.124 | 175.898 | 209.833 | 100.267 | 71.326 | 154.643 |
| Total Current Liabilities
| 4,614.102 | 11,359.386 | 11,645.15 | 10,116.814 | 6,248.182 | 3,382.216 | 1,981.561 | 1,227.513 | 951.097 | 871.557 | 698.138 | 604.093 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 1,637.743 | 2,344.807 | 3,109.546 | 4,296.847 | 1,740.871 | 107.654 | 252.802 | 256 | 90 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 108.732 | 380.189 | 147.267 | 109.365 | 71.521 | 48.09 | 42.781 | 31.591 | 17.171 | 7.912 | 3.093 | 0 |
| Deferred Tax Liabilities Non-Current
| 13.727 | 18.884 | 23.674 | 25.524 | 23.424 | 6.651 | 5.414 | 51.35 | 57.642 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 70.645 | 25.163 | 302.95 | 358.986 | 1,238.121 | 93.482 | 13.537 | 6.08 | 2.046 | 23.377 | 10.689 | 0 |
| Total Non-Current Liabilities
| 1,830.847 | 2,769.044 | 3,583.437 | 4,790.722 | 1,867.307 | 255.877 | 314.534 | 345.021 | 166.86 | 31.289 | 13.782 | 0 |
| Total Liabilities
| 6,444.949 | 14,128.43 | 15,228.586 | 14,907.536 | 8,115.489 | 3,638.093 | 2,296.095 | 1,572.534 | 1,117.957 | 902.846 | 711.92 | 604.093 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 33.543 | 47.603 | 4.726 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 2,605.583 | 870.275 | 871.058 | 684.413 | 674.016 | 434.206 | 425.98 | 420 | 360 | 300 | 100 | 67 |
| Retained Earnings
| -5,044.529 | -5,555.517 | -1,974.813 | -935.786 | 689.384 | 212.935 | 187.959 | 174.891 | 69.93 | 50.543 | 55.202 | 17.47 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 109.392 | 43.025 | 99.813 | -33.543 | -47.603 | -4.726 | 28.756 | 43.188 | 30.55 | -0 | 0 |
| Other Total Stockholders Equity
| 5,005.128 | 3,612.881 | 3,582.094 | 1,376.415 | 1,412.237 | 228.507 | 204.559 | 213.578 | 43.188 | 30.55 | 15.462 | 9.155 |
| Total Shareholders Equity
| 2,566.182 | -962.969 | 2,503.835 | 1,303.472 | 2,742.095 | 828.044 | 813.772 | 808.469 | 473.118 | 381.093 | 170.664 | 93.626 |
| Total Equity
| 3,061.148 | -503.217 | 3,431.983 | 2,192.991 | 3,903.207 | 1,283.575 | 1,008.934 | 965.549 | 593.749 | 445.387 | 214.942 | 106.354 |
| Total Liabilities & Shareholders Equity
| 9,506.097 | 13,625.213 | 18,660.569 | 17,100.527 | 12,018.695 | 4,921.668 | 3,305.029 | 2,538.084 | 1,711.706 | 1,348.232 | 926.862 | 710.447 |